Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes
- PMID: 19203718
- DOI: 10.1016/j.jtemb.2008.10.001
Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes
Abstract
Arsenic, a known environmental toxicant, is ubiquitously present in the environment. Arsenic trioxide (ATO), an anti-acute promyelocytic leukemia (APL) drug, is associated with cardiac toxicity. It is reported to induce cardiac arrhythmia via altering various ion channels involved in the repolarization phase of cardiac action potential. The exact molecular mechanism of cardiovascular adverse effect due to ATO exposure has not been fully elucidated except for alteration on ion channels. To evaluate the cytotoxic effect of ATO on cardiac myocytes, primary culture of myocytes was treated with different doses (30, 60 and 90 microM) of ATO for various periods (24, 48 and 72 h). Cardiac toxicity was assessed by monitoring cell viability, mitochondrial and deoxyribonucleic acid (DNA) integrity, reactive oxygen species (ROS) generation, calcium overload and apoptosis. ATO exposure caused alteration in mitochondrial integrity, generation of ROS, calcium overload and apoptosis in cardiac cells in dose- and duration-dependent manner. There was no DNA fragmentation. Hence our results show that ATO causes apoptosis in cardiomyocytes by generation of ROS and the induction of calcium overload.
Similar articles
-
Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells.Toxicol Appl Pharmacol. 2008 Jan 15;226(2):140-52. doi: 10.1016/j.taap.2007.09.020. Epub 2007 Nov 19. Toxicol Appl Pharmacol. 2008. PMID: 18022205
-
Arsenic trioxide toxicity in H9c2 myoblasts--damage to cell organelles and possible amelioration with Boerhavia diffusa.Cardiovasc Toxicol. 2013 Jun;13(2):123-37. doi: 10.1007/s12012-012-9191-x. Cardiovasc Toxicol. 2013. PMID: 23161055
-
Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.Ann Hematol. 2013 Sep;92(9):1207-20. doi: 10.1007/s00277-013-1763-8. Epub 2013 May 5. Ann Hematol. 2013. PMID: 23645216
-
Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells.Toxicol Appl Pharmacol. 2010 May 1;244(3):385-92. doi: 10.1016/j.taap.2010.02.012. Epub 2010 Mar 1. Toxicol Appl Pharmacol. 2010. PMID: 20193703 Review.
-
An Overview on Arsenic Trioxide-Induced Cardiotoxicity.Cardiovasc Toxicol. 2019 Apr;19(2):105-119. doi: 10.1007/s12012-018-09504-7. Cardiovasc Toxicol. 2019. PMID: 30617460 Review.
Cited by
-
Small molecule FICD inhibitors suppress endogenous and pathologic FICD-mediated protein AMPylation.bioRxiv [Preprint]. 2024 Jul 16:2024.07.13.603377. doi: 10.1101/2024.07.13.603377. bioRxiv. 2024. PMID: 39071275 Free PMC article. Preprint.
-
Protective Effects of Crocetin on Arsenic Trioxide-induced Oxidative Stress in Human Umbilical Vein Endothelial Cells.In Vivo. 2021 Nov-Dec;35(6):3157-3163. doi: 10.21873/invivo.12610. In Vivo. 2021. PMID: 34697146 Free PMC article.
-
Potential Protective Effect of Spirulina Platensis on Sodium Arsenite Induced Cardiotoxicity in Male Rats.Tissue Barriers. 2022 Apr 3;10(2):1983330. doi: 10.1080/21688370.2021.1983330. Epub 2021 Oct 6. Tissue Barriers. 2022. PMID: 34615441 Free PMC article.
-
Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats.Mol Med Rep. 2020 Dec;22(6):5271-5281. doi: 10.3892/mmr.2020.11587. Epub 2020 Oct 14. Mol Med Rep. 2020. PMID: 33173984 Free PMC article.
-
Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity.Front Cell Dev Biol. 2020 Jun 3;8:434. doi: 10.3389/fcell.2020.00434. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32582710 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources